BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 2828029)

  • 1. The BPV1-E2 trans-acting protein can be either an activator or a repressor of the HPV18 regulatory region.
    Thierry F; Yaniv M
    EMBO J; 1987 Nov; 6(11):3391-7. PubMed ID: 2828029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes.
    Bernard BA; Bailly C; Lenoir MC; Darmon M; Thierry F; Yaniv M
    J Virol; 1989 Oct; 63(10):4317-24. PubMed ID: 2476572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of human papillomavirus type 11 enhancer and E6 promoter by activating and repressing proteins from the E2 open reading frame: functional and biochemical studies.
    Chin MT; Hirochika R; Hirochika H; Broker TR; Chow LT
    J Virol; 1988 Aug; 62(8):2994-3002. PubMed ID: 2839716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancers and trans-acting E2 transcriptional factors of papillomaviruses.
    Hirochika H; Broker TR; Chow LT
    J Virol; 1987 Aug; 61(8):2599-606. PubMed ID: 3037119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trans-activation of an upstream early gene promoter of bovine papilloma virus-1 by a product of the viral E2 gene.
    Haugen TH; Cripe TP; Ginder GD; Karin M; Turek LP
    EMBO J; 1987 Jan; 6(1):145-52. PubMed ID: 3034572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional analysis of E2-mediated repression of the HPV18 P105 promoter.
    Thierry F; Howley PM
    New Biol; 1991 Jan; 3(1):90-100. PubMed ID: 1645591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel constitutive enhancer element and an associated binding protein: implications for human papillomavirus type 11 enhancer regulation.
    Chin MT; Broker TR; Chow LT
    J Virol; 1989 Jul; 63(7):2967-76. PubMed ID: 2542607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells.
    Moon MS; Lee CJ; Um SJ; Park JS; Yang JM; Hwang ES
    Gynecol Oncol; 2001 Feb; 80(2):168-75. PubMed ID: 11161855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements.
    Dong G; Broker TR; Chow LT
    J Virol; 1994 Feb; 68(2):1115-27. PubMed ID: 8289341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The carboxy-terminal domain shared by the bovine papillomavirus E2 transactivator and repressor proteins contains a specific DNA binding activity.
    McBride AA; Schlegel R; Howley PM
    EMBO J; 1988 Feb; 7(2):533-9. PubMed ID: 2835232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the E2 gene product of the cottontail rabbit papillomavirus reveals a common mechanism of transactivation among papillomaviruses.
    Giri I; Yaniv M
    J Virol; 1988 May; 62(5):1573-81. PubMed ID: 2833608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional trans-activation by the human papillomavirus type 16 E2 gene product.
    Phelps WC; Howley PM
    J Virol; 1987 May; 61(5):1630-8. PubMed ID: 3033289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The specific DNA recognition sequence of the bovine papillomavirus E2 protein is an E2-dependent enhancer.
    Hawley-Nelson P; Androphy EJ; Lowy DR; Schiller JT
    EMBO J; 1988 Feb; 7(2):525-31. PubMed ID: 2835231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional regulation of the human papillomavirus-16 E6-E7 promoter by a keratinocyte-dependent enhancer, and by viral E2 trans-activator and repressor gene products: implications for cervical carcinogenesis.
    Cripe TP; Haugen TH; Turk JP; Tabatabai F; Schmid PG; Dürst M; Gissmann L; Roman A; Turek LP
    EMBO J; 1987 Dec; 6(12):3745-53. PubMed ID: 2448139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repression of the human papillomavirus type 18 enhancer by the cellular transcription factor Oct-1.
    Hoppe-Seyler F; Butz K; zur Hausen H
    J Virol; 1991 Oct; 65(10):5613-8. PubMed ID: 1654457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence-specific and general transcriptional activation by the bovine papillomavirus-1 E2 trans-activator require an N-terminal amphipathic helix-containing E2 domain.
    Haugen TH; Turek LP; Mercurio FM; Cripe TP; Olson BJ; Anderson RD; Seidl D; Karin M; Schiller J
    EMBO J; 1988 Dec; 7(13):4245-53. PubMed ID: 2854060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bovine papillomavirus E2 gene regulates expression of the viral E5 transforming gene.
    Prakash SS; Horwitz BH; Zibello T; Settleman J; DiMaio D
    J Virol; 1988 Oct; 62(10):3608-13. PubMed ID: 2843663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bovine papillomavirus transcriptional regulation: localization of the E2-responsive elements of the long control region.
    Spalholz BA; Lambert PF; Yee CL; Howley PM
    J Virol; 1987 Jul; 61(7):2128-37. PubMed ID: 3035214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein.
    Steger G; Corbach S
    J Virol; 1997 Jan; 71(1):50-8. PubMed ID: 8985322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple cooperative interactions constrain BPV-1 E2 dependent activation of transcription.
    Sowden M; Harrison S; Ashfield R; Kingsman AJ; Kingsman SM
    Nucleic Acids Res; 1989 Apr; 17(8):2959-72. PubMed ID: 2542891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.